University of Denver

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, University of Denver sits in the top decile of US sponsors by registered trial count (#1,049 of 15,742 sponsors by registered trial count).

13 total trials 1 currently recruiting 10 completed top decile by trial count

University of Denver: 13 sponsored US clinical trials, 1 recruiting.

University of Denver sponsors 13 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 10 completed. 1 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Dysthymic Disorder, with 1 trials.

Top-decile sponsor footprint

University of Denver ranks in the top decile of sponsors by registered trial count (#1,049 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

A 90/100

10 of 10 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

13 total, page 1 of 1

RECRUITING NA

In-person vs. Virtual Delivery of a Group-based Prevention of Postpartum Depression

NCT05766475
ACTIVE NOT RECRUITING NA

Fostering Healthy Futures for Teens: An RCT

NCT03707366
NOT YET RECRUITING NA

Electronic, Self-Guided Safety Plan in Adolescents: Project SAFER

NCT06868407
COMPLETED NA

Investigating the Neural Systems That Support the Beneficial Effects of Positive Emotion on Stress Regulation

NCT04496258
COMPLETED NA

Single-Session Intervention Targeting Self-Injurious Behavior in Adolescents

NCT04498143
COMPLETED NA

Threat Interpretation Bias as Cognitive Marker and Treatment Target in Pediatric Anxiety

NCT04245501
COMPLETED NA

Activating Happiness in Cancer: A Positive Psychology Workshop for Patients, Survivors, and Caregivers

NCT03569657
COMPLETED NA

Evaluation of High School-based Relationship Education

NCT03559855
COMPLETED NA

Safety Awareness For Empowerment (SAFE): An RCT With Young People Experiencing Homelessness

NCT04183400
COMPLETED

Muscle Activation Characteristics During Spinal Manipulation in Healthy and Low Back Pain Participants

NCT03483714
COMPLETED Phase 3

The Effects and Mechanisms of Mindfulness Based Cognitive Therapy (MBCT) on Depressive Symptoms and Depression Relapse

NCT01145872
COMPLETED Phase 1

Effects of Therapist Behavior on the Treatment of Depressed Adolescents

NCT00073359
COMPLETED NA

Double-blind Placebo Surgery Trial for Treatment of Parkinson's Disease

NCT03347955

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 3 1

Therapeutic Areas

Dysthymic Disorder 1
Delinquency 1
Educational Problems 1
Mental Health Impairment 1
Adolescent Development 1
Sexual Behavior 1
Child Neglect 1
Child Abuse 1
Depressive Disorder 1
Back Pain 1

What is open in the University of Denver pipeline

1 recruiting of 13 indexed (8% open); 10 completed (77%).

Phase mix: 1 late (III/IV) vs 1 early (I/II) (balanced across stages).

Top condition: Dysthymic Disorder (1 trial), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Denver: open-pipeline peers nationwide

Peers matched on 13 registered trials and 8% open enrollment, not the therapeutic-area sidebar.

University of Denver sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 12.912.91313.1 0%2%4%6%8%10% Total trials Recruiting share University of DenverAdaptimmuneAgennixAkili Interactive LabsAlumisAndrei IagaruBioXcel TherapeuticsCorporal Michael J. Crescenz VA Medical CenterFresenius Medical Care North America
University of Denver sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Denver sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 13 trials (± recruiting share)

Sponsors near 8% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this University of Denver page

13 registered trials is a research-attention snapshot, not an endorsement of University of Denver or any single study.

  • 1 of University of Denver's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Dysthymic Disorder is the condition University of Denver studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Dysthymic Disorder trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

University of Denver pipeline card: 13 registered trials from official public datasets.Report a data error.